Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



MOORE ALISON Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 144 Form 144 - Report of proposed sale of securities:
03/24/2023 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 558,094 shares @ $0
Granted 432,738 options to buy @ $5.04, valued at $2.2M
03/16/2023 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Paid exercise price by delivering 8,351 shares @ $5.5071, valued at $46k
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/25/2022 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 737,179 options to buy @ $9.69, valued at $7.1M
03/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2020 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 24,233 shares @ $42, valued at $1M
Sold 11,031 shares @ $42, valued at $463.3k
Exercised 24,233 options to buy @ $2.27, valued at $55k
Exercised 11,031 options to buy @ $2.27, valued at $25k
10/09/2020 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 5,065 shares @ $41, valued at $207.7k
Sold 39,509 shares @ $41, valued at $1.6M
Exercised 5,065 options to buy @ $2.27, valued at $11.5k
Exercised 30,199 options to buy @ $2.27, valued at $68.6k
10/08/2020 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 44,574 shares @ $40, valued at $1.8M
Exercised 35,264 options to buy @ $2.27, valued at $80k
08/14/2020 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Exercised 32,451 options to buy @ $2.27, valued at $73.7k
06/18/2020 4 MOORE ALISON (Director) has filed a Form 4 on CODEXIS, INC.
Txns: Granted 17,905 shares @ $0
06/16/2020 3 MOORE ALISON (Director) has filed a Form 3 on CODEXIS, INC.
03/20/2020 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 30,800 shares @ $0
Granted 109,600 options to buy @ $18.22, valued at $2M
03/18/2020 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 3,750 shares @ $19.1947, valued at $72k
09/18/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/30/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2019 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 47,205 shares @ $26.7441, valued at $1.3M
Sold 1,623 shares @ $27.3069, valued at $44.3k
Exercised 48,828 options to buy @ $2.27, valued at $110.8k
03/15/2019 4 MOORE ALISON (Chief Technical Officer) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 37,050 shares @ $0
Granted 83,500 options to buy @ $26.89, valued at $2.2M
10/10/2018 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy